US Healthcare Price Transparency Policy Struggles
Analysis based on 11 articles · First reported Feb 10, 2026 · Last updated Feb 24, 2026
The ongoing efforts to implement healthcare price transparency, driven by both Donald Trump and Joe Biden administrations, have not significantly empowered patients to shop for better prices. Instead, the data is primarily being utilized by health systems and insurers for contract negotiations, potentially leading to shifts in how healthcare providers are compensated and fostering a new industry of data analysis startups like Turquoise Health.
Healthcare price transparency policies, initially championed by Donald Trump in 2019 and further pursued by both his and Joe Biden's administrations, aimed to reduce healthcare costs by enabling patients to compare prices. Despite federal mandates and increased enforcement by the Centers for Medicare & Medicaid Services, compliance among hospitals has been low, and the available data is often confusing. Research from institutions like Yale University indicates that patients rarely use this information for shopping. Instead, health insurers, such as Blue Cross Blue Shield of Minnesota, and healthcare providers are leveraging the data for contract negotiations, leading to a new market for startups like Turquoise Health that analyze this pricing information. The American Hospital Association has highlighted the complexities hospitals face in providing standardized price data due to varied contracts.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard